

Free delivery for orders over 89€*.
* in metropolitan France and excluding drugs
Indications: Piascledine® 300 is a drug indicated for symptomatic treatment (pain and functional discomfort) with delayed effect of osteoarthritis of the hip and knee
This medicine contains a combination of plant extracts.
Drug based on avocado and soy unsaponifiables indicated in the symptomatic treatment (pain and discomfort during movements) with delayed effect of osteoarthritis of the knee (Requires a medical diagnosis).
PIASCLÉDINE 300 box of 90 capsules
Also available in boxes of 30 capsules and 60 capsules
p capsules | |
Unsaponifiables of avocado oil | 100 mg |
Unsaponifiables of soybean oil | 200 mg |
Active ingredients: Unsaponifiables of avocado oil, Unsaponifiables of soya oil
Excipients: Butylated hydroxytoluene, Erythrosine, Yellow iron oxide, Gelatin, Polysorbate 80, Colloidal anhydrous silica, Titanium dioxide
The effect of this drug during pregnancy or lactation is not known. The evaluation of the possible risk related to its use is individual: ask your pharmacist or your doctor for advice.
The capsules should be swallowed with a glass of water, in the middle of meals.
1 capsule per day.
In the treatment of osteoarthritis, the effect of this medication is slow to appear: relief generally appears only after 1 to 2 months of treatment.
The drug treatment does not dispense with measures to fight against possible overweight. It is also recommended to practice an adapted physical activity to strengthen the muscles and maintain the mobility of the joint.
Rare regurgitation with a lipidic smell, allergic reaction.
Diarrhea, stomach pain.
Exceptionally: liver damage.
If you have experienced an adverse reaction that may be due to this medicine, you can report it by downloading the form.
See the Piascledine® 300 leaflet in the "Attached documents" tab
Indications: Piascledine® 300 is a drug indicated for symptomatic treatment (pain and functional discomfort) with delayed effect of osteoarthritis of the hip and knee
Sinovial® is indicated in cases of pain or reduced mobility in order to restore the physiological and rheological properties of arthritic joints.
Flector effigel is a medicine containing an anti-inflammatory and an analgesic, it is used in the short term local treatment, in adults and children over 15 years old, in case of benign trauma: sprain, strain, or contusion.
Intra-articular injection of hyaluronic acid forarthropathy causing pain or limited mobility. This medical device is a regulated healthcare product, and carries the CE mark.
- Restore the viscoelastic properties of synovial fluid
- Reduce pain
- Improve joint mobility
Indication : Sinovial® One is indicated in case of pain or limitations of mobility due to degenerative or post-traumatic affections or to alterations of the joint and tendons, in order to restore the physiological and rheological conditions of arthrosic joints.
1 pre-filled syringe of 2.5ml 50MG/2.5 ML of hyaluronic acid
Sinovial® HL is indicated for pain or reduced mobility due to degenerative diseases (osteoarthritis), post-traumatic diseases or tendinopathy linked to joint alterations.
Indication: Indicated for the symptomatic treatment of osteoarthritis, particularly of the hip and knee. Chondrosulf contains chondroitin sulfate and is indicated for adults (over 15 years of age).
Chondrosulf is available in several dosages:
Chondrolsulf 400 mg box 84 capsules
Chondrolsulf 800 mg box 30 capsules
OSTENIL® Tendon is a medical device indicated for the treatment of pain and limitation of mobility in the case of tendon disorders.
Indicated for the symptomatic treatment of osteoarthritis, particularly of the hip and knee. Chondrosulf contains chondroitin sulfate and is indicated for adults (over 15).
Chondrosulf is available in several dosages:
Chondrolsulf 400 mg box 84 capsules
Chondrolsulf 800 mg box 30 capsules
This medicine is used as a ground modifier especially during infectious and viral conditions, flu-like conditions, inflammatory rheumatic conditions and during arthrosis.
Indications: This drug is indicated in adults (over 15 years), in the symptomatic treatment of pain of tendino-ligamentary origin, and post-traumatic pain: sprains and bruises. This drug is indicated in adults in the treatment of painful flare-ups of osteoarthritis of the knee, after a first medical opinion.
Injection treatment of mild to moderate osteoarthritis of the knee or hip.
DUROLANE® has also been approved for the symptomatic treatment associated with mild to moderate osteoarthritis pain of the ankles, shoulders, elbows, wrists, fingers and toes.
Pain relief improves joint function and helps restore quality of life.
Indications: Phytostandard of harpagophytum and willow Pileje is a food supplement to improve joint comfort.
The extracts of harpagophytum and willow are obtained through the patented Phytostandard® process known for its respect for the integrity of the plant's compounds.
Indicated for the symptomatic treatment of osteoarthritis, particularly of the hip and knee. Chondrosulf contains chondroitin sulfate and is indicated for adults (over 15).
Chondrosulf is available in several dosages:
Chondrolsulf 400 mg box 84 capsules
Chondrolsulf 800 mg box 30 capsules
SYNOVIUM HCS viscoelastic devices are indicated for the symptomatic treatment of gonarthrosis, in particular to reduce pain and restore joint mobility by replacing and supplementing the elasto-viscosity of the synovial fluid in arthritic joints.
The therapeutic indications are all types of painful gonarthrosis:
- Primary gonarthrosis (Kelgreen radiological stages I, II and III)
- Gonarthrosis and associated general factors:
- Ineffectiveness of usual treatments.
- Intolerance and/or contraindication to NSAIDs and/or analgesics.
- Taking anticoagulants, poly-medication (hypertension, diabetes, obesity, cardiovascular and gastrointestinal problems).
- Contraindications related to the fitting of a prosthesis: young patients and various contraindications related to the patient's condition.
- Early gonarthrosis in young patients.
- Gonarthrosis secondary to trauma and the aftermath of articular fractures.